Suppr超能文献

CD8 肿瘤浸润淋巴细胞耗竭异质性及其在弥漫性大 B 细胞淋巴瘤中的潜在机制的意义。

The significance of CD8 tumor-infiltrating lymphocytes exhaustion heterogeneity and its underlying mechanism in diffuse large B-cell lymphoma.

机构信息

Department of Pathology, North Sichuan Medical College, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, China; Department of Pathology, Institute of Basic Medicine and Forensic Medicine, North Sichuan Medical College, Nanchong 637000, China.

Department of Pathology, North Sichuan Medical College, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, China; Key Lab of Process Analysis and Control of Sichuan Universities, Yibin University, Yibin, Sichuan 644000, China.

出版信息

Int Immunopharmacol. 2024 Aug 20;137:112447. doi: 10.1016/j.intimp.2024.112447. Epub 2024 Jun 22.

Abstract

CD8 tumor-infiltrating lymphocytes (TILs) exhaustion is a major barrier to effective tumor control in diffuse large B-cell lymphoma (DLBCL) and may consist of heterogeneous populations with different functional states. We profiled the CD8TILs exhaustion heterogeneity and explored its clinical significance as well as the underlying mechanism through single-cell RNA sequencing (n = 7), bulk RNA sequencing (n = 3300), immunohistochemistry (n = 116), and reverse transcription-quantitative polymerase chain reaction (n = 95), and somatic mutation data (n = 48). Our results demonstrated that exhausted CD8TILs in DLBCL were composed of progenitor and terminal states characterized by CCL5 and TUBA1B, respectively. High terminally exhausted CD8TILs indicated an immunosuppressive tumor microenvironment, activated B-cell-like subtype, inferior prognosis, and poor response to immune checkpoint blockade therapy in DLBCL. Our study further demonstrated that the CD39/A2AR-related signaling may be the potential pathway that promoted the transition of progenitor toward terminally exhausted CD8TILs in DLBCL. Furthermore, the CD39/A2AR-related pathway in DLBCL may be regulated by BATF and STAT3 in exhausted CD8TILs, and MYD88 mutation in tumor cells. Our study highlights CD8TILs exhaustion heterogeneity and its possible regulatory mechanism provides a novel prognostic indicator and can facilitate the optimization of individualized immunotherapy.

摘要

CD8 肿瘤浸润淋巴细胞 (TILs) 耗竭是弥漫性大 B 细胞淋巴瘤 (DLBCL) 中有效控制肿瘤的主要障碍,可能由具有不同功能状态的异质群体组成。我们通过单细胞 RNA 测序 (n=7)、批量 RNA 测序 (n=3300)、免疫组织化学 (n=116) 和逆转录定量聚合酶链反应 (n=95) 以及体细胞突变数据 (n=48) 对 CD8TILs 耗竭异质性及其临床意义和潜在机制进行了分析。我们的研究结果表明,DLBCL 中的耗竭 CD8TILs 由祖细胞和终末状态组成,分别由 CCL5 和 TUBA1B 特征化。高水平的终末耗竭 CD8TILs 表明免疫抑制性肿瘤微环境、激活 B 细胞样亚型、预后不良以及对 DLBCL 免疫检查点阻断治疗的反应差。我们的研究进一步表明,CD39/A2AR 相关信号通路可能是促进祖细胞向 DLBCL 中终末耗竭 CD8TILs 转化的潜在途径。此外,DLBCL 中的 CD39/A2AR 相关通路可能受耗竭 CD8TILs 中的 BATF 和 STAT3 以及肿瘤细胞中的 MYD88 突变调节。我们的研究强调了 CD8TILs 耗竭异质性及其可能的调节机制,为提供了一种新的预后指标,并有助于优化个体化免疫治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验